0       0

AMDA Long Term Care Medicine - 2013


CEXP - Meet the Expert: What's New in Fall and Fracture Prevention in Long Term Care


Mar 23, 2013 6:30am ‐ Mar 23, 2013 7:45am

Standard: $24.00

Description

Accreditation
The American Medical Directors Association (AMDA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement:
The American Medical Directors Association designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMDCP Credit Designation:
This session has been approved for a total of clinical 1.0 credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).

Session Description:
This session will summarize recent evidence informing fall and fracture prevention in long term care residents.  Dr. Colón-Emeric will discuss risk stratification, implementation of multi-factorial fall risk reduction programs, new pharmacologic treatments for osteoporosis of interest in long term care, and the controversy surrounding calcium and vitamin D supplements.  There is an additional fee of $55 to participate in this session and pre-registration is required.  To ensure an optimal learning experience, space is limited so sign-up as soon as possible by checking the appropriate box on the registration form. Breakfast will be provided.

Learning Objective(s):

  • Use validated tools to determine a resident’s fall and fracture risk.
  • Describe the elements of a multi-factorial fall reduction program, and their implementation in long term care facilities.
  • Identify benefits and risks of the major classes of osteoporosis pharmacotherapies in long term care residents.
  • Discuss the role of calcium and vitamin D in fall and fracture prevention in long term care. 






Speaker(s):
Cathleen Colón-Emeric, MD, MHS 

Disclosure(s):
Amgen- Consultant, research grant; Novartis: Consultant, Research Grant; CardioBis, Inc.: Co-owner; Intellectual Property: 2 provisional patients, cardiovascular indications for Bisphosphonates 

Reference(s):
None

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content